Subscribe
Advertising
Contact Us
Medical News
Articles
TV & Video
Authors
About Medicine Magazine
Home
MEDICAL NEWS
Health
|
Biotechnology
|
Pharmaceutical
Biotechnology Headlines
Today is September 28, 2024. All times in Eastern Daylight Time.
Naveris to Showcase Advances in Precision Surveillance for HPV-Associated Oropharyngeal Cancer Using the NavDx® Test at the 2024 ASTRO Annual Meeting
09/28/2024 - 09:05 AM
PhotoPharmics Announces First Subject Completes FDA Pivotal Clinical Trial for the Celeste Device in Parkinson’s
09/28/2024 - 09:00 AM
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults
09/27/2024 - 07:38 PM
Naveris Presents New Data on the NavDx® test for HPV-Associated Oropharyngeal Cancer at the 2024 AAO-HNS Annual Meeting
09/27/2024 - 07:09 PM
New Data at ASTRO 2024 Shows Castle Biosciences’ DecisionDx®-SCC Test Provides More Precise Risk Stratification Than BWH Staging Alone to Guide Intensified Treatment for Immune Suppressed Patients with High-Risk Cutaneous Squamous Cell Carcinoma
09/27/2024 - 05:15 PM
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
09/27/2024 - 04:32 PM
bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing
09/27/2024 - 04:30 PM
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/27/2024 - 04:05 PM
Savara Announces New Employment Inducement Grant
09/27/2024 - 04:05 PM
Prothena Announces Leadership Team Updates
09/27/2024 - 04:05 PM
Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé
09/27/2024 - 03:26 PM
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells
09/27/2024 - 12:00 PM
Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting
09/27/2024 - 11:06 AM
Iambic Therapeutics Named to the Endpoints 11 List of Biotech’s Most Promising Startups
09/27/2024 - 09:00 AM
LEO Pharma Presents Late-breaking Tralokinumab Data at EADV 2024 for Moderate-to-Severe Atopic Dermatitis (AD) in the Difficult-to-Treat Head and Neck Region
09/27/2024 - 09:00 AM
BlueRock Therapeutics’ Investigational Cell Therapy Bemdaneprocel for Parkinson’s Disease Shows Positive Data at 24-Months
09/27/2024 - 08:30 AM
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024
09/27/2024 - 08:15 AM
Savara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
09/27/2024 - 08:05 AM
Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company
09/27/2024 - 08:00 AM
Astria Therapeutics to Present at Upcoming Global Angioedema Forum
09/27/2024 - 08:00 AM
Odyssey Therapeutics Announces Formation of Scientific Advisory Board
09/27/2024 - 08:00 AM
Endpoints News Announces the 2024 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups
09/27/2024 - 07:00 AM
Septerna Announces Initiation of Phase 1 Clinical Trial with SEP-786, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
09/27/2024 - 07:00 AM
Caresyntax Awarded 2024 German AI Prize for Advancing Surgical Intelligence
09/27/2024 - 06:52 AM
LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China
09/27/2024 - 06:30 AM
1
2
3
4
5
6
7
8
9
Next »
Get Business Wire News on Your Website
Terms of Use
|
© 2024 Business Wire
Medical News
|
Articles
|
TV & Video
|
Authors
|
About Houston Medicine
|
Subscribe
|
Advertising
|
Masthead
|
Contact Us
Copyright 2004. World Publishing LLC. All rights reserved.
